{"id":37708,"date":"2017-01-06T04:08:53","date_gmt":"2017-01-06T09:08:53","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=37708"},"modified":"2017-01-06T04:08:53","modified_gmt":"2017-01-06T09:08:53","slug":"vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708","title":{"rendered":"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Vitality Biopharma Inc (OTCMKTS:VBIO)<\/strong> ended 2016 on a happy note by announcing approvals from two regulators for expanding development activities for novel cannabinoid pharmaceutical prodrugs. The company said that both the State of California Research Advisory Panel, as well as, the U.S. Drug Enforcement Agency (DEA) has given their nods for expanding activities of expansion at company\u2019s facilities. Vitality Biopharma can now leverage its novel cannabinoid pharmaceutical prodrugs development activities in the factories.<\/p>\n<h2 style=\"text-align: justify;\"><strong>Ensured adequate on-site measures for diverting Schedule I controlled substances<\/strong><\/h2>\n<p style=\"text-align: justify;\">The company said that it worked closely with DEA to make sure that proper measures were taken on site to prevent leisurely use of Schedule I controlled substances. The company is working on development of proprietary prodrugs of CBD and THC and Cannabinoid is a vital component in the process.<\/p>\n<p style=\"text-align: justify;\">Vitality Biopharma said that U.S. Food &amp; Drug Administration (FDA) reviewed and approved the use of Cannabinoid in proprietary prodrugs development after analysis. Meanwhile, the company said that it has also received research permits from California Research Advisory Panel (California Attorney General\u2019s Office) so as to start off with the cannabinoid pharmaceutical development activities. These will be targeted towards seeking regulatory approval of its clinical trials.<\/p>\n<h2 style=\"text-align: justify;\"><strong>California\u2019s Legalization and Strict Norms<\/strong><\/h2>\n<p style=\"text-align: justify;\">California has been among the first few states in the U.S. to legalize the use of cannabis for medical and recreational purposes and Pharma R&amp;D. Despite legalization, both, FDA as well as DEA, has strict norms and policies in place to closely regulate the approvals.<\/p>\n<p style=\"text-align: justify;\">The company says that its THC and CBD prodrugs are meant for providing relief to psychoactive side effects with the help of company\u2019s prodrug technology.<\/p>\n<p style=\"text-align: justify;\">Vitality Biopharma\u2019s senior executive associated with the process, Dr. Brandon Zipp stated that the company\u2019s research will now be scaled up and it will \u201caggressively pursue clinical testing of compounds.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vitality Biopharma Inc (OTCMKTS:VBIO) ended 2016 on a happy note by announcing approvals from two regulators for expanding development activities for novel cannabinoid pharmaceutical prodrugs. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":37691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12177,12178,12176],"stock_ticker":[],"class_list":["post-37708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-otcmktsvbio","tag-vitality-biopharma-inc","tag-vitality-biopharma-inc-otcmktsvbio","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Vitality Biopharma Inc (OTCMKTS:VBIO) ended 2016 on a happy note by announcing approvals from two regulators for expanding development activities for novel cannabinoid pharmaceutical prodrugs. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-06T09:08:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png\" \/>\n\t<meta property=\"og:image:width\" content=\"646\" \/>\n\t<meta property=\"og:image:height\" content=\"220\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development\",\"datePublished\":\"2017-01-06T09:08:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\"},\"wordCount\":328,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png\",\"keywords\":[\"OTCMKTS:VBIO\",\"Vitality Biopharma Inc\",\"Vitality Biopharma Inc (OTCMKTS:VBIO)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\",\"name\":\"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png\",\"datePublished\":\"2017-01-06T09:08:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png\",\"width\":646,\"height\":220,\"caption\":\"Vitality Biopharma Inc\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708","og_locale":"en_US","og_type":"article","og_title":"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development - Wall Street PR","og_description":"Vitality Biopharma Inc (OTCMKTS:VBIO) ended 2016 on a happy note by announcing approvals from two regulators for expanding development activities for novel cannabinoid pharmaceutical prodrugs. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-01-06T09:08:53+00:00","og_image":[{"width":646,"height":220,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png","type":"image\/png"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development","datePublished":"2017-01-06T09:08:53+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708"},"wordCount":328,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png","keywords":["OTCMKTS:VBIO","Vitality Biopharma Inc","Vitality Biopharma Inc (OTCMKTS:VBIO)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708","url":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708","name":"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png","datePublished":"2017-01-06T09:08:53+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2016\/12\/Vitality-Biopharma-Inc.png","width":646,"height":220,"caption":"Vitality Biopharma Inc"},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/vitality-biopharma-inc-otcmktsvbio-to-scale-up-novel-cannabinoid-pharmaceutical-prodrugs-development-37708#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Vitality Biopharma Inc (OTCMKTS:VBIO) To Scale Up Novel Cannabinoid Pharmaceutical Prodrugs Development"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=37708"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37708\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/37691"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=37708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=37708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=37708"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=37708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}